Compare organizations

Digestive Cancers Europe (DiCE), the European umbrella organisation representing patients with digestive cancer, welcomes the opportunity to provide feedback to the evaluation roadmap to the EU general pharmaceuticals legislation. We welcome the EC’s intentions to improve access to affordable medicines and enhance the existing provisions on access to biosimilar medicines.

BEUC supports the European Commission’s initiative to evaluate and revise the general pharmaceutical legislation to improve access to medicines. We agree with the main gaps identified in the roadmap and corrective measures, but have additional recommendations. These are the most pressing issues and necessary changes for consumers: Unmet medical needs: Antimicrobial resistance is a global public health-threat.

The European Commission proposal for a revised EUs pharmaceutical legislation is a step in the right direction as it includes recommendations from BEUC on ways to improve access to medicines in Europe. We strongly support measures to increase transparency on public funding for biomedical research, facilitate the development of medicines by non-profit entities, and enhance EU cooperation and action in the prevention…

BEUC, The European Consumer Organisation appreciates the opportunity to provide input to the European Commission’s ongoing evaluation of the need for a legislative proposal on a European Health Data Space. We consider that the evaluation provides a timely opportunity to ensure that sensitive data of European patients and consumers used for scientific advancements is well protected and serves societal interests.

Digestive Cancers Europe (DiCE) applauds the European Commission for the proposal on European Health Data Space. DiCE believes that health data can improve health systems and advance research, especially in area of cancers such as digestive, where better diagnostic tools and treatment are urgently needed. In relation to EHDS we would like to share the following reflections. 1.